About this trial
Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Maternal age: 20-49 years;
Natural conception;
Single pregnancy;
Plan to have routine prenatal examinations and give birth in the research center;
Disqualifiers
Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy;
Assisted reproduction;
Multiple pregnancy;
Fetus has a known deformity or genetic defects;
Trial population
This project intends to recruit pregnant women who go to the research center for routine prenatal examination and give birth.
Trial design
Cohort
Prospective
Treatments tested in this trial
Questionnaire survey and specimen collection
Other interventionQuestionnaire survey, clinical follow-up and specimens collection.
Treatment groups
Trial outcomes
Primary outcomes
Maternal outcomes
Including pregnancy-induced hypertension, preterm delivery, abortion, delivery way and so on. They are diagnosed by clinicians and the data is gathered from medical records.
Neonatal outcomes
Birth weight(in gram), birth height (in centimetre), gestational week (in week) and other neonatal diseases. They are diagnosed by clinicians and the data is gathered from medical records.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.